About US
Contact us
-
Sanofi falls short in Q3 as diabetes and MS sales disappointTo make up for a slow and painful decline of its aging diabetes unit, Sanofi has been counting on newer market entrieslike Aubagio and Lemtrada to treat multiple sclerosis. And during the third quarte2017/11/3
-
Teva cuts guidance yet again as Copaxone copies, generics pressure take their tollOn a day that Teva chairman Sol Barer described as “the beginning of the next chapter for our company,” all analysts got was more of the same. For the third time in the last four quarters, the comp2017/11/3
-
Insys takes $150M charge in Q3 as it works to settle Subsys probeRight on the heels of the high-profile arrest of Insys' billionaire founder John Kapoor, the drugmaker has recorded a $150 million charge as it works to put its Subsys legal problems in the past.2017/11/2
-
With pricing talk losing steam, lawmakers take on reducing costs due to wasted drugsCongress has failed to make progress on drug pricing reform, buta group of lawmakers are pushing for something they hope will be more agreeable: finding solutions to reduce drug waste, and so costs to2017/11/2
-
As Amazon entry into pharma looms, CEOs see plenty of room for change in distributionOnline retailing giant Amazon has yet to publicly disclose any plans to get into drug sales, but the mere speculation has pharma CEOs thinking, and speaking, about how it could entirely remake their w2017/11/1
-
Under various pressures, Novo Nordisk is cautious on 2018 guidanceNovo Nordisk is navigating a tough stretch thanks to increased competition and new state laws adding to the already-tough pricing pressure on the U.S. insulin market. But the drugmaker has a plan to c2017/11/1
-
Bristol-Myers Squibb could double patient numbers for Opdivo in kidney cancerNow that Bristol-Myers Squibb’s Opdivo has safely posted growth in 2017, all eyes are on what the drug can pull off next year. Its move into a larger kidney cancer market will be central to that equat2017/10/31
-
As generics market stalls, Novartis said to weigh sale of copycat skin medicationsPick up one, cast off another. Just as Novartis agreed to buy a radiotherapy company, it's reportedly considering a selloff of its generic dermatology business, a once-hot field that's been hit by p2017/10/31
-
WPP Health & Wellness invests in online health community to tap patient insightWPP’s latest investment is all about patients. WPP Health & Wellness haspartnered(PDF) with The Mighty, an online community for patients and caregivers, to help boost patient centricity for client2017/10/30
-
Merck hack causes Gardasil sales miss in Q3 as drugmaker borrows from CDCWorking to recover from a damaging cyberattack, Merck reported that its star HPV vaccine missed sales expectations in the third quarter as it had to borrow from the CDC's stockpile to fulfill orders.2017/10/30